Detection of chromosomal aberrations by fluorescence in situ hybridization in cervicovaginal biopsies from women exposed to diethylstilbestrol in utero

Epidemiologic studies have associated estrogens with human neoplasms such as those in the endometrium, cervix, vagina, breast, and liver. Perinatal exposure to natural (17β-estradiol [17β-E2]) and synthetic (diethylstilbestrol [DES]) estrogens induces neoplastic changes in humans and rodents. Previo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of gynecological cancer 2006, Vol.16 (1), p.318-324
Hauptverfasser: Hajek, R. A., King, D. W., HernÁNdez-Valero, M. A., Kaufman, R. H., Liang, J. C., Chilton, J. A., Edwards, C. L., Wharton, J. T., Jones, L. A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 324
container_issue 1
container_start_page 318
container_title International journal of gynecological cancer
container_volume 16
creator Hajek, R. A.
King, D. W.
HernÁNdez-Valero, M. A.
Kaufman, R. H.
Liang, J. C.
Chilton, J. A.
Edwards, C. L.
Wharton, J. T.
Jones, L. A.
description Epidemiologic studies have associated estrogens with human neoplasms such as those in the endometrium, cervix, vagina, breast, and liver. Perinatal exposure to natural (17β-estradiol [17β-E2]) and synthetic (diethylstilbestrol [DES]) estrogens induces neoplastic changes in humans and rodents. Previous studies demonstrated that neonatal 17β-E2 treatment of mice results in increased nuclear DNA content of cervicovaginal epithelium that precedes histologically evident neoplasia. In order to determine whether this effect was associated with chromosomal changes in humans, the frequencies of trisomy of chromosomes 1, 7, 11, and 17 were evaluated by the fluorescence in situ hybridization (FISH) technique in cervicovaginal tissue from 19 DES-exposed and 19 control women. The trisomic frequencies were significantly elevated in 4 of the 19 (21%) DES-exposed patients. One patient presented with trisomy of chromosomes 1, 7, and 11, while trisomy of chromosome 7 was observed in one patient. There were two patients with trisomy of chromosome 1. Trisomy of chromosomes 1, 7, 11, and 17 was not observed in the cervicovaginal tissue taken from control patients. These data suggest that DES-induced chromosomal trisomy may be an early event in the development of cervicovaginal neoplasia in humans.
doi_str_mv 10.1136/ijgc-00009577-200601000-00051
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2552818989</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1048891X24151626</els_id><sourcerecordid>2552818989</sourcerecordid><originalsourceid>FETCH-LOGICAL-b2941-12510b580e066ede7250f6d075fb5d3fb746f2c57c1062ce7b30e7b6ffa9b583</originalsourceid><addsrcrecordid>eNqVkc1u1DAUhSNERUvhFZAlxDJgO7GTLFigFgpSpW66YGfF9nXjwYkH25lh-iJ9XZxmgBUSeOHfc46v_RXFG4LfElLxd3Zzp0qcW8eapqQYc0zyatli5ElxRhhlJamr9mme47ot2458PS2ex7hZTBR3z4pTwuuacUbPiodLSKCS9RPyBqkh-NFHP_YO9RJC6JeTiOQBGTf7AFHBpADZCUWbZjQcZLDa3j_Kll0FYWeV3_V3dsoZ0vpttBCRyblo70eYEPzY-ggaJY-0hTQcXEzWSYgpeLdkzAmCf1GcmN5FeHkcz4vbTx9vLz6X1zdXXy4-XJeSdjUpCWUES9ZiwJyDhoYybLjGDTOS6crIpuaGKtYogjlV0MgK544b03fZVp0Xr9fYbfDf51yD2Pg55NKjoIzRlrRd22XV-1Wlgo8xgBHbYMc-HATBYqEiFiriFxXxm4p4pJL9r463zHIE_cd9xJAF9SrYe5dfH7-5eQ9BDNC7NIi_0c62q9UG-Yd2NjuisgsgbUOGKrS3_1xhuybJcfOfj_sJBgbD5w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2552818989</pqid></control><display><type>article</type><title>Detection of chromosomal aberrations by fluorescence in situ hybridization in cervicovaginal biopsies from women exposed to diethylstilbestrol in utero</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Hajek, R. A. ; King, D. W. ; HernÁNdez-Valero, M. A. ; Kaufman, R. H. ; Liang, J. C. ; Chilton, J. A. ; Edwards, C. L. ; Wharton, J. T. ; Jones, L. A.</creator><creatorcontrib>Hajek, R. A. ; King, D. W. ; HernÁNdez-Valero, M. A. ; Kaufman, R. H. ; Liang, J. C. ; Chilton, J. A. ; Edwards, C. L. ; Wharton, J. T. ; Jones, L. A.</creatorcontrib><description>Epidemiologic studies have associated estrogens with human neoplasms such as those in the endometrium, cervix, vagina, breast, and liver. Perinatal exposure to natural (17β-estradiol [17β-E2]) and synthetic (diethylstilbestrol [DES]) estrogens induces neoplastic changes in humans and rodents. Previous studies demonstrated that neonatal 17β-E2 treatment of mice results in increased nuclear DNA content of cervicovaginal epithelium that precedes histologically evident neoplasia. In order to determine whether this effect was associated with chromosomal changes in humans, the frequencies of trisomy of chromosomes 1, 7, 11, and 17 were evaluated by the fluorescence in situ hybridization (FISH) technique in cervicovaginal tissue from 19 DES-exposed and 19 control women. The trisomic frequencies were significantly elevated in 4 of the 19 (21%) DES-exposed patients. One patient presented with trisomy of chromosomes 1, 7, and 11, while trisomy of chromosome 7 was observed in one patient. There were two patients with trisomy of chromosome 1. Trisomy of chromosomes 1, 7, 11, and 17 was not observed in the cervicovaginal tissue taken from control patients. These data suggest that DES-induced chromosomal trisomy may be an early event in the development of cervicovaginal neoplasia in humans.</description><identifier>ISSN: 1048-891X</identifier><identifier>EISSN: 1525-1438</identifier><identifier>DOI: 10.1136/ijgc-00009577-200601000-00051</identifier><identifier>PMID: 16445652</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Adenocarcinoma, Clear Cell - chemically induced ; Adenocarcinoma, Clear Cell - epidemiology ; Adenocarcinoma, Clear Cell - pathology ; Adult ; Biopsy, Needle ; Case-Control Studies ; cervical ; Chromosome Aberrations - chemically induced ; Chromosome Aberrations - statistics &amp; numerical data ; Chromosomes ; diethylstilbestrol ; Diethylstilbestrol - adverse effects ; Diethylstilbestrol - therapeutic use ; Estrogens ; Female ; fluorescence in situ hybridization (FISH) ; Humans ; In Situ Hybridization, Fluorescence ; Incidence ; Patients ; Probability ; Reference Values ; Risk Assessment ; Sensitivity and Specificity ; Tissue Culture Techniques ; Trisomy ; Uterine Cervical Neoplasms - chemically induced ; Uterine Cervical Neoplasms - epidemiology ; Uterine Cervical Neoplasms - pathology ; Uterus - drug effects ; Vaginal Neoplasms - chemically induced ; Vaginal Neoplasms - epidemiology ; Vaginal Neoplasms - pathology</subject><ispartof>International journal of gynecological cancer, 2006, Vol.16 (1), p.318-324</ispartof><rights>2006, IGCS</rights><rights>2006 IGCS and ESGO.</rights><rights>Copyright © 2006 Blackwell Publishing Ltd.</rights><rights>2006 2006, IGCS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-b2941-12510b580e066ede7250f6d075fb5d3fb746f2c57c1062ce7b30e7b6ffa9b583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4009,27902,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16445652$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hajek, R. A.</creatorcontrib><creatorcontrib>King, D. W.</creatorcontrib><creatorcontrib>HernÁNdez-Valero, M. A.</creatorcontrib><creatorcontrib>Kaufman, R. H.</creatorcontrib><creatorcontrib>Liang, J. C.</creatorcontrib><creatorcontrib>Chilton, J. A.</creatorcontrib><creatorcontrib>Edwards, C. L.</creatorcontrib><creatorcontrib>Wharton, J. T.</creatorcontrib><creatorcontrib>Jones, L. A.</creatorcontrib><title>Detection of chromosomal aberrations by fluorescence in situ hybridization in cervicovaginal biopsies from women exposed to diethylstilbestrol in utero</title><title>International journal of gynecological cancer</title><addtitle>Int J Gynecol Cancer</addtitle><description>Epidemiologic studies have associated estrogens with human neoplasms such as those in the endometrium, cervix, vagina, breast, and liver. Perinatal exposure to natural (17β-estradiol [17β-E2]) and synthetic (diethylstilbestrol [DES]) estrogens induces neoplastic changes in humans and rodents. Previous studies demonstrated that neonatal 17β-E2 treatment of mice results in increased nuclear DNA content of cervicovaginal epithelium that precedes histologically evident neoplasia. In order to determine whether this effect was associated with chromosomal changes in humans, the frequencies of trisomy of chromosomes 1, 7, 11, and 17 were evaluated by the fluorescence in situ hybridization (FISH) technique in cervicovaginal tissue from 19 DES-exposed and 19 control women. The trisomic frequencies were significantly elevated in 4 of the 19 (21%) DES-exposed patients. One patient presented with trisomy of chromosomes 1, 7, and 11, while trisomy of chromosome 7 was observed in one patient. There were two patients with trisomy of chromosome 1. Trisomy of chromosomes 1, 7, 11, and 17 was not observed in the cervicovaginal tissue taken from control patients. These data suggest that DES-induced chromosomal trisomy may be an early event in the development of cervicovaginal neoplasia in humans.</description><subject>Adenocarcinoma, Clear Cell - chemically induced</subject><subject>Adenocarcinoma, Clear Cell - epidemiology</subject><subject>Adenocarcinoma, Clear Cell - pathology</subject><subject>Adult</subject><subject>Biopsy, Needle</subject><subject>Case-Control Studies</subject><subject>cervical</subject><subject>Chromosome Aberrations - chemically induced</subject><subject>Chromosome Aberrations - statistics &amp; numerical data</subject><subject>Chromosomes</subject><subject>diethylstilbestrol</subject><subject>Diethylstilbestrol - adverse effects</subject><subject>Diethylstilbestrol - therapeutic use</subject><subject>Estrogens</subject><subject>Female</subject><subject>fluorescence in situ hybridization (FISH)</subject><subject>Humans</subject><subject>In Situ Hybridization, Fluorescence</subject><subject>Incidence</subject><subject>Patients</subject><subject>Probability</subject><subject>Reference Values</subject><subject>Risk Assessment</subject><subject>Sensitivity and Specificity</subject><subject>Tissue Culture Techniques</subject><subject>Trisomy</subject><subject>Uterine Cervical Neoplasms - chemically induced</subject><subject>Uterine Cervical Neoplasms - epidemiology</subject><subject>Uterine Cervical Neoplasms - pathology</subject><subject>Uterus - drug effects</subject><subject>Vaginal Neoplasms - chemically induced</subject><subject>Vaginal Neoplasms - epidemiology</subject><subject>Vaginal Neoplasms - pathology</subject><issn>1048-891X</issn><issn>1525-1438</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqVkc1u1DAUhSNERUvhFZAlxDJgO7GTLFigFgpSpW66YGfF9nXjwYkH25lh-iJ9XZxmgBUSeOHfc46v_RXFG4LfElLxd3Zzp0qcW8eapqQYc0zyatli5ElxRhhlJamr9mme47ot2458PS2ex7hZTBR3z4pTwuuacUbPiodLSKCS9RPyBqkh-NFHP_YO9RJC6JeTiOQBGTf7AFHBpADZCUWbZjQcZLDa3j_Kll0FYWeV3_V3dsoZ0vpttBCRyblo70eYEPzY-ggaJY-0hTQcXEzWSYgpeLdkzAmCf1GcmN5FeHkcz4vbTx9vLz6X1zdXXy4-XJeSdjUpCWUES9ZiwJyDhoYybLjGDTOS6crIpuaGKtYogjlV0MgK544b03fZVp0Xr9fYbfDf51yD2Pg55NKjoIzRlrRd22XV-1Wlgo8xgBHbYMc-HATBYqEiFiriFxXxm4p4pJL9r463zHIE_cd9xJAF9SrYe5dfH7-5eQ9BDNC7NIi_0c62q9UG-Yd2NjuisgsgbUOGKrS3_1xhuybJcfOfj_sJBgbD5w</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>Hajek, R. A.</creator><creator>King, D. W.</creator><creator>HernÁNdez-Valero, M. A.</creator><creator>Kaufman, R. H.</creator><creator>Liang, J. C.</creator><creator>Chilton, J. A.</creator><creator>Edwards, C. L.</creator><creator>Wharton, J. T.</creator><creator>Jones, L. A.</creator><general>Elsevier Inc</general><general>Copyright Blackwell Publishing Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>2006</creationdate><title>Detection of chromosomal aberrations by fluorescence in situ hybridization in cervicovaginal biopsies from women exposed to diethylstilbestrol in utero</title><author>Hajek, R. A. ; King, D. W. ; HernÁNdez-Valero, M. A. ; Kaufman, R. H. ; Liang, J. C. ; Chilton, J. A. ; Edwards, C. L. ; Wharton, J. T. ; Jones, L. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b2941-12510b580e066ede7250f6d075fb5d3fb746f2c57c1062ce7b30e7b6ffa9b583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adenocarcinoma, Clear Cell - chemically induced</topic><topic>Adenocarcinoma, Clear Cell - epidemiology</topic><topic>Adenocarcinoma, Clear Cell - pathology</topic><topic>Adult</topic><topic>Biopsy, Needle</topic><topic>Case-Control Studies</topic><topic>cervical</topic><topic>Chromosome Aberrations - chemically induced</topic><topic>Chromosome Aberrations - statistics &amp; numerical data</topic><topic>Chromosomes</topic><topic>diethylstilbestrol</topic><topic>Diethylstilbestrol - adverse effects</topic><topic>Diethylstilbestrol - therapeutic use</topic><topic>Estrogens</topic><topic>Female</topic><topic>fluorescence in situ hybridization (FISH)</topic><topic>Humans</topic><topic>In Situ Hybridization, Fluorescence</topic><topic>Incidence</topic><topic>Patients</topic><topic>Probability</topic><topic>Reference Values</topic><topic>Risk Assessment</topic><topic>Sensitivity and Specificity</topic><topic>Tissue Culture Techniques</topic><topic>Trisomy</topic><topic>Uterine Cervical Neoplasms - chemically induced</topic><topic>Uterine Cervical Neoplasms - epidemiology</topic><topic>Uterine Cervical Neoplasms - pathology</topic><topic>Uterus - drug effects</topic><topic>Vaginal Neoplasms - chemically induced</topic><topic>Vaginal Neoplasms - epidemiology</topic><topic>Vaginal Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hajek, R. A.</creatorcontrib><creatorcontrib>King, D. W.</creatorcontrib><creatorcontrib>HernÁNdez-Valero, M. A.</creatorcontrib><creatorcontrib>Kaufman, R. H.</creatorcontrib><creatorcontrib>Liang, J. C.</creatorcontrib><creatorcontrib>Chilton, J. A.</creatorcontrib><creatorcontrib>Edwards, C. L.</creatorcontrib><creatorcontrib>Wharton, J. T.</creatorcontrib><creatorcontrib>Jones, L. A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>International journal of gynecological cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hajek, R. A.</au><au>King, D. W.</au><au>HernÁNdez-Valero, M. A.</au><au>Kaufman, R. H.</au><au>Liang, J. C.</au><au>Chilton, J. A.</au><au>Edwards, C. L.</au><au>Wharton, J. T.</au><au>Jones, L. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Detection of chromosomal aberrations by fluorescence in situ hybridization in cervicovaginal biopsies from women exposed to diethylstilbestrol in utero</atitle><jtitle>International journal of gynecological cancer</jtitle><addtitle>Int J Gynecol Cancer</addtitle><date>2006</date><risdate>2006</risdate><volume>16</volume><issue>1</issue><spage>318</spage><epage>324</epage><pages>318-324</pages><issn>1048-891X</issn><eissn>1525-1438</eissn><abstract>Epidemiologic studies have associated estrogens with human neoplasms such as those in the endometrium, cervix, vagina, breast, and liver. Perinatal exposure to natural (17β-estradiol [17β-E2]) and synthetic (diethylstilbestrol [DES]) estrogens induces neoplastic changes in humans and rodents. Previous studies demonstrated that neonatal 17β-E2 treatment of mice results in increased nuclear DNA content of cervicovaginal epithelium that precedes histologically evident neoplasia. In order to determine whether this effect was associated with chromosomal changes in humans, the frequencies of trisomy of chromosomes 1, 7, 11, and 17 were evaluated by the fluorescence in situ hybridization (FISH) technique in cervicovaginal tissue from 19 DES-exposed and 19 control women. The trisomic frequencies were significantly elevated in 4 of the 19 (21%) DES-exposed patients. One patient presented with trisomy of chromosomes 1, 7, and 11, while trisomy of chromosome 7 was observed in one patient. There were two patients with trisomy of chromosome 1. Trisomy of chromosomes 1, 7, 11, and 17 was not observed in the cervicovaginal tissue taken from control patients. These data suggest that DES-induced chromosomal trisomy may be an early event in the development of cervicovaginal neoplasia in humans.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>16445652</pmid><doi>10.1136/ijgc-00009577-200601000-00051</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1048-891X
ispartof International journal of gynecological cancer, 2006, Vol.16 (1), p.318-324
issn 1048-891X
1525-1438
language eng
recordid cdi_proquest_journals_2552818989
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adenocarcinoma, Clear Cell - chemically induced
Adenocarcinoma, Clear Cell - epidemiology
Adenocarcinoma, Clear Cell - pathology
Adult
Biopsy, Needle
Case-Control Studies
cervical
Chromosome Aberrations - chemically induced
Chromosome Aberrations - statistics & numerical data
Chromosomes
diethylstilbestrol
Diethylstilbestrol - adverse effects
Diethylstilbestrol - therapeutic use
Estrogens
Female
fluorescence in situ hybridization (FISH)
Humans
In Situ Hybridization, Fluorescence
Incidence
Patients
Probability
Reference Values
Risk Assessment
Sensitivity and Specificity
Tissue Culture Techniques
Trisomy
Uterine Cervical Neoplasms - chemically induced
Uterine Cervical Neoplasms - epidemiology
Uterine Cervical Neoplasms - pathology
Uterus - drug effects
Vaginal Neoplasms - chemically induced
Vaginal Neoplasms - epidemiology
Vaginal Neoplasms - pathology
title Detection of chromosomal aberrations by fluorescence in situ hybridization in cervicovaginal biopsies from women exposed to diethylstilbestrol in utero
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T23%3A42%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Detection%20of%20chromosomal%20aberrations%20by%20fluorescence%20in%20situ%20hybridization%20in%20cervicovaginal%20biopsies%20from%20women%20exposed%20to%20diethylstilbestrol%20in%20utero&rft.jtitle=International%20journal%20of%20gynecological%20cancer&rft.au=Hajek,%20R.%20A.&rft.date=2006&rft.volume=16&rft.issue=1&rft.spage=318&rft.epage=324&rft.pages=318-324&rft.issn=1048-891X&rft.eissn=1525-1438&rft_id=info:doi/10.1136/ijgc-00009577-200601000-00051&rft_dat=%3Cproquest_cross%3E2552818989%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2552818989&rft_id=info:pmid/16445652&rft_els_id=S1048891X24151626&rfr_iscdi=true